Mankind Pharma Limited (BOM:543904)
2,320.35
-57.40 (-2.41%)
At close: Jun 1, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 980.71 billion as of June 1, 2026. Its market cap has decreased by -4.92% in one year.
Market Cap
980.71B
Enterprise Value
1.02T
Revenue
142.78B
Ranking
n/a
PE Ratio
51.27
Stock Price
2,320.35
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 980.71B, an increase of 72.13%. That is a compound annual growth rate of 19.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 957.84B | 5.64% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.49T |
| Dr. Reddy's Laboratories | 1.08T |
| Lupin | 1.04T |
| Abbott India | 571.12B |
| GlaxoSmithKline Pharmaceuticals | 374.17B |
| J. B. Chemicals & Pharmaceuticals | 348.81B |
| AstraZeneca Pharma India | 216.79B |
| Granules India | 191.37B |